280 related articles for article (PubMed ID: 9821868)
1. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
Sandhoff K; Kolter T
Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell.
Sandhoff K; Kolter T; Van Echten-Deckert G
Ann N Y Acad Sci; 1998 Jun; 845():139-51. PubMed ID: 9668348
[TBL] [Abstract][Full Text] [Related]
4. Intracellular trafficking of glycosphingolipids: role of sphingolipid activator proteins in the topology of endocytosis and lysosomal digestion.
Sandhoff K; Klein A
FEBS Lett; 1994 Jun; 346(1):103-7. PubMed ID: 8206147
[TBL] [Abstract][Full Text] [Related]
5. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
[TBL] [Abstract][Full Text] [Related]
6. Saposin B mobilizes lipids from cholesterol-poor and bis(monoacylglycero)phosphate-rich membranes at acidic pH. Unglycosylated patient variant saposin B lacks lipid-extraction capacity.
Remmel N; Locatelli-Hoops S; Breiden B; Schwarzmann G; Sandhoff K
FEBS J; 2007 Jul; 274(13):3405-20. PubMed ID: 17561962
[TBL] [Abstract][Full Text] [Related]
7. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids.
Kolter T; Sandhoff K
Annu Rev Cell Dev Biol; 2005; 21():81-103. PubMed ID: 16212488
[TBL] [Abstract][Full Text] [Related]
8. Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
Sadeghlar F; Remmel N; Breiden B; Klingenstein R; Schwarzmann G; Sandhoff K
Biochimie; 2003; 85(3-4):439-48. PubMed ID: 12770782
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo.
Klein A; Henseler M; Klein C; Suzuki K; Harzer K; Sandhoff K
Biochem Biophys Res Commun; 1994 May; 200(3):1440-8. PubMed ID: 8185598
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipid activator proteins (SAPs) are stored together with glycosphingolipids in the infantile neuronal ceroid-lipofuscinosis (INCL).
Tyynelä J; Baumann M; Henseler M; Sandhoff K; Haltia M
Am J Med Genet; 1995 Jun; 57(2):294-7. PubMed ID: 7668348
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis, processing, and targeting of sphingolipid activator protein (SAP )precursor in cultured human fibroblasts. Mannose 6-phosphate receptor-independent endocytosis of SAP precursor.
Vielhaber G; Hurwitz R; Sandhoff K
J Biol Chem; 1996 Dec; 271(50):32438-46. PubMed ID: 8943309
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical localization of sphingolipid activator protein 2 (SAP-2) in normal and SAP-deficient fibroblasts.
Paton BC; Hughes JL; Harzer K; Poulos A
Eur J Cell Biol; 1990 Feb; 51(1):157-64. PubMed ID: 2109697
[TBL] [Abstract][Full Text] [Related]
13. The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin.
Lefrancois S; Zeng J; Hassan AJ; Canuel M; Morales CR
EMBO J; 2003 Dec; 22(24):6430-7. PubMed ID: 14657016
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the biochemistry of sphingolipidoses.
Kolter T; Sandhoff K
Brain Pathol; 1998 Jan; 8(1):79-100. PubMed ID: 9458169
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal degradation of membrane lipids.
Kolter T; Sandhoff K
FEBS Lett; 2010 May; 584(9):1700-12. PubMed ID: 19836391
[TBL] [Abstract][Full Text] [Related]
16. [Lysosomal enzymes, sphingolipid activator proteins, and protective protein].
Suzuki Y
Nihon Rinsho; 1995 Dec; 53(12):2887-91. PubMed ID: 8577030
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins.
Linke T; Wilkening G; Lansmann S; Moczall H; Bartelsen O; Weisgerber J; Sandhoff K
Biol Chem; 2001 Feb; 382(2):283-90. PubMed ID: 11308026
[TBL] [Abstract][Full Text] [Related]
18. Saposin C is required for lipid presentation by human CD1b.
Winau F; Schwierzeck V; Hurwitz R; Remmel N; Sieling PA; Modlin RL; Porcelli SA; Brinkmann V; Sugita M; Sandhoff K; Kaufmann SH; Schaible UE
Nat Immunol; 2004 Feb; 5(2):169-74. PubMed ID: 14716313
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
[TBL] [Abstract][Full Text] [Related]
20. [Disorders of sphingolipid activator proteins].
Suzuki Y
Nihon Rinsho; 1995 Dec; 53(12):3025-7. PubMed ID: 8577053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
